Detect molecular players in arthritis pathology in vivo with Revvity’s IVISense™ Arthritis Fluorescent Imaging Panel.
Standard methods to assess arthritis in animal models typically involve external measurements of limbs such as paw volume, paw thickness, and redness. While these methods determine the overall progression of disease, they do not access the underlying biology associated with the visible effects of the disease. Since arthritis involves not only inflammation pathways but also changes in vasculature and bone morphology, using fluorescent agents that measure each of these changes individually allow for a more complete assessment of the overall clinical pathology.
Revvity' IVISense Arthritis fluorescent panel contains a carefully selected, pre-validated bundle of probes designed for researchers to gain a better understanding of arthritis disease and its progression.
IVISense Arthritis Fluorescent Imaging Panel includes the following six probes:
| Part Number | Fluorescent Probe | Biological Target |
|---|
| NEV10003 | IVISense Pan Cathepsin 680 (ProSense 680) | Pan-cathepsin activatable probe:
Lysosomal marker of inflammatory cells |
| NEV10011EX | IVISense Vascular 750 (AngeioSense 750EX) | Vascular probe:
Leaks into sites of edema |
| NEV10020EX | IVISense Osteo 680 (OsteoSense 680EX) | Bone turnover targeted probe:
Detects areas of exposed hydroxyapatite |
| NEV10126 | IVISense MMP 680 (MMPSense 680) | Pan-MMP activatable probe:
Secreted marker of inflammatory cells, bone/cartilage degradation |
| NEV11000 | IVISense Cat K 680 FAST | Cathepsin K activatable probe:
Secreted marker of osteoclasts, bone degradation |
| NEV11098 | IVISense Cat B 750 FAST | Cathepsin B activatable probe:
Lysosomal marker of inflammatory cells |
For research use only. Not for use in diagnostic procedures.
